Latest News
|
More Articles...
- Abbott Unveils Late-Breaking Data Showing the World’s First Dual-Chamber Leadless Pacemaker Study Met All Three Primary Endpoints
- Adagio Medical Announces Completion of Enrollment in Cryocure-VT Trial, Maps the Pathway to CE-Mark of vCLAS™ VT Ablation Catheter
- Appsens AS: Twice as Many as Anticipated Have Unidentified Atrial Fibrillation
- Axon Therapies Cohort Study Extends Benefit to 6 Months with Early Clinical Data from REBALANCE-HF Randomized Clinical Trial
- Progressing Clinical Evidence: CathVision Announces First Patient Enrolled In Persistent AF Study at OLV Hospital Aalst
- Corvia Medical Releases Two-year Clinical Trial Results Confirming Sustained Benefit and Safety of Its Atrial Shunt in Heart Failure Patients
- DX Technology Demonstrates High Detection Accuracy for Atrial Fibrillation (AF) in Single-Chamber ICD Patients
- Endotronix Announces Enrollment
- The FLOW-AF multicenter, randomized controlled trial shows Ablacon’s Electrographic Flow® (EGF®) Mapping software (Ablamap®) results in improved ablation outcomes in persistent atrial fibrillation
- Acesion Pharma announces positive phase 2 data from Atrial Fibrillation clinical trial primary endpoint achieved
|
|
